No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Established in 1987 and based in Asan, South Korea, Kyongbo Pharmaceutical Co., Ltd is a key player in the South Korean pharmaceutical market, primarily focusing on the production and distribution of active pharmaceutical ingredients (APIs). Its API offerings span general, cephalosporin, and anti-cancer categories. Beyond APIs, the company also supplies a range of finished pharmaceutical products, including prescription medications for anesthetic, cardiovascular, and digestive uses, as well as antibiotics, alongside its over-the-counter (OTC) drug portfolio. Kyongbo Pharmaceutical extends its reach internationally, exporting its goods to 30 countries worldwide. The company officially adopted its current name, Kyongbo Pharmaceutical Co., Ltd, in March 2002, having previously been known as Kyongbo Chemical Co. Ltd.
www.kbpharma.co.krNo one on the platform currently holds 214390.KS.
No tracked institution reports a position in 214390.KS as of their last filing.
No one on the platform has traded 214390.KS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 214390.KSKyongbo Pharmaceutical Co., Ltd | $5360.00 | -0.37% | $128.1B | — |
| 000020.KSDongwha Pharm.Co.,Ltd | $5070.00 | -0.59% | $140.5B | — |
| 000230.KSIldong Holdings Co., Ltd. | $6020.00 | +1.18% | $69.5B | — |
| 001360.KSSAMSUNG PHARM. Co., Ltd. | $1378.00 | -0.72% | $129.7B | — |
| 002390.KSHANDOK Inc. | $8640.00 | -2.81% | $112.2B | — |
| 002620.KSJeil Pharma Holdings Inc | $7620.00 | -0.78% | $117.0B | — |
| 003060.KSAprogen Biologics Inc. | $1655.00 | +0.85% | $21.8B | — |
Source: Financial Modeling Prep · peers by sector/industry